Ayvakit 25 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26FQQ3L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $51,362
Award facts
- Contract value 100% obligated
- $51,362.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $51,362.20, was awarded on November 18, 2025, to AmerisourceBergen Drug Corp for the supply of AYVAKIT (avapritinib) 25 mg tablets in a 30-count package. The award is a firm fixed-price, non-set-aside contract with a completion date of December 10, 2025, and is funded by the Defense Logistics Agency (DLA), a component of the Department of Defense responsible for medical and pharmaceutical supply chain operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support platform enabling the company to supply a broad range of pharmaceutical products, specialty medications, and medical supplies to support military healthcare programs worldwide, including services to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its established capability to meet federal medical procurement requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FQQ3L?
SPE2DR26FQQ3L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FQQ3L worth?
The government has obligated $51,362 on SPE2DR26FQQ3L.
Is contract SPE2DR26FQQ3L an order under another contract?
Yes. SPE2DR26FQQ3L is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ3L competed?
The extent of competition for SPE2DR26FQQ3L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award